Physician profile
Michael Arnz
NPI 1013910603
$1,062.24
in general payments reported to CMS, 2019-2025
21 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $93.25 · 2021: $65.88 · 2022: $175 · 2023: $161 · 2024: $260 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $240.90 | 2020-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Claw II |
| Organogenesis INC. | $236.09 | 2019-2023 | Puraply |
| Zimmer Biomet Holdings, INC. | $97.14 | 2019-2021 | |
| Prism Medical | $90.75 | 2025 | |
| Depuy Synthes Sales INC. | $88.24 | 2022-2024 | Motoband Cp, Motoband, Va-Lcp |
| Integra Lifesciences Corporation | $35.79 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Horizon Therapeutics Plc | $29.44 | 2020-2021 | |
| Tactile Systems Technology INC | $25.25 | 2020-2021 | |
| Convatec INC. | $24.92 | 2024 | |
| Heron Therapeutics, INC. | $23.03 | 2021-2022 | |
| Nevro Corp. | $19.25 | 2024 | Senza |
| Axogen | $18.41 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.05 | 2024 | Exparel |
| Bioventus LLC | $16.23 | 2023 | Exogen Ultrasound Bone Healing System |
| Medline Industries Lp | $15.60 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $15.49 | 2023 | Qutenza |
| Biotissue Holdings INC. | $14.43 | 2024 | |
| Kerecis Limited | $14.09 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $13.94 | 2025 | Nuzyra |
| Davol INC. | $13.52 | 2024 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Arnz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.